Skip to main content
Timothy Cloughesy, MD, Neurology, Los Angeles, CA, Ronald Reagan UCLA Medical Center

TimothyFrancisCloughesyMD

Neurology • Los Angeles, CA

Neurooncology

Professor of Neuology/Director, UCLA NeuroOncology Program

Join to view full profile

Dr. Cloughesy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cloughesy's full profile

Already have an account?

  • Office

    UCLA Medical Center
    710 Westwood Plaza, 1-230 RNRC
    Los Angeles, CA 90095
    Phone+1 310-825-5321
    Fax+1 310-825-5321
  • Is this information wrong?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1988 - 1991
  • Creighton University School of Medicine/Maricopa Medical Center (Phoenix)
    Creighton University School of Medicine/Maricopa Medical Center (Phoenix)Internship, Internal Medicine, 1987 - 1988
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2026
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Kazia Executes Agreement to Commence GBM Agile Pivotal Study
    Kazia Executes Agreement to Commence GBM Agile Pivotal StudyOctober 16th, 2020
  • Kazia Therapeutics Executes Agreement to Begin GBM Agile Pivotal Study
    Kazia Therapeutics Executes Agreement to Begin GBM Agile Pivotal StudyOctober 15th, 2020
  • Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-Oncology Annual Meeting
    Toca 5 Phase 3 Trial Results Presented at the Society for Neuro-Oncology Annual MeetingNovember 22nd, 2019
  • Join now to see all

Grant Support

  • UCLA IRB 08-09-042: Phase I Trial Of Aflibercept (Vegf Trap) With Radiation TheNational Center For Research Resources2010
  • UCLA IRB # 06-04-104 "A Phase I/II, Dual-Center, Open-Label Trial Of The SAFENational Center For Research Resources2009–2010
  • UCLA IRB # 06-04-016 "Phase II Trial Of Bevacizumab In Combination With TemozNational Center For Research Resources2007–2010
  • Phase I/II Study Of OSI-774 (ERLOTINIB) And CCI-779 (TEMSIROLIMUS) In PatientNational Center For Research Resources2007–2010
  • Phase II Single Arm Trial Of VEGF TRAP In Patients With Recurrent Temozolomide-National Center For Research Resources2009
  • UCLA IRB (PENDING) "A Phase I/II Studies Of BAY 43-9006 (SORAFENIB) In CombinNational Center For Research Resources2007–2009
  • UCLA IRB #05-12-061 "A Phase I Study Of Vorinostat (Suberoylanilide HydroxamiNational Center For Research Resources2007–2009
  • Recurrent Temozolomide-Resistant Malignant GliomasNational Center For Research Resources2008
  • Clinical Trial: A Phase II Trial Of Poly-Iclc In Patients With Recurrent AnaplasNational Center For Research Resources2008
  • "A Phase I/II Studies Of BAY 43-9006 (SORAFENIB) In CombinNational Center For Research Resources2008
  • A Biomarker And Phase II Study Of GW 572016 In Recurrent Malignant Glioma (NaNational Center For Research Resources2007–2008
  • Consortium Therapeutic Studies Of Primary Central Nervous System MalignanciesNational Cancer Institute2007–2008
  • Consortium Therapeutic Studies Of Primary Central Nervi*National Center For Research Resources2005–2008
  • Phase II Trial Of EMD 121974 For Recurrent Glioblastoma: A Clinical Trial WitNational Center For Research Resources2006–2007
  • A Phase II Trial Of Poly-Iclc In Patients With Recurrent Anaplastic Glioma NNational Center For Research Resources2005–2007
  • A Multicenter, Open-Label, Randomized, Uncontrolled, Phase IIA Trial In SubjeNational Center For Research Resources2006
  • ZD1839 For Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or GLINational Center For Research Resources2005–2006
  • A Phase II Trial Of STI-571 ( NSC 716051) In Patients With Recurrent MeningioNational Center For Research Resources2005–2006
  • A Phase I/II Trial Of OSI-774 In Patients With Recurrent Malignant Gliomas AnNational Center For Research Resources2005–2006
  • A Modified Phase I/II Trial Of Rapamycin In Patients With Malignant GliomasNational Center For Research Resources2005–2006
  • Consortium Therapeutic Studies Of Primary Central Nervi*National Cancer Institute2005–2006
  • Phase II Trial Of Poly-Iclc For Glioblastoma [Nabtc 01-05]National Center For Research Resources2005
  • Phase I/II Of R115777 In Patients With Recurrent Malignant GliomasNational Center For Research Resources2005
  • Phase I-II Trial Of STI-571 (Nsc 716051) In Patients With Recurrent MalignantNational Center For Research Resources2005
  • ZD1839 For Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or Gli...National Center For Research Resources2004
  • Quantified Gene Expression Improves PrognosisNational Center For Research Resources2004
  • Phase II Evaluation Of Fenretinide (Nsc 374551) As A SNational Center For Research Resources2004
  • Phase I/II Trial Of OSI-774 In Patients With RecurrentNational Center For Research Resources2004
  • Phase I/II Trial Of CCI-779 In Patients With Malignant Gliomas (Nabtc 01-01)National Center For Research Resources2004
  • Phase I/II Of R115777 For Recurrent Malignant GliomasNational Center For Research Resources2004
  • Modified Phase I/II Trial Of Rapamycin In Patients WitNational Center For Research Resources2004
  • Consortium Therapeutic Studies Of CNS MalignanciesNational Cancer Institute2004
  • Gene Expression Prognosis &Trtmt Response Stratification In PATS W/ GliomaNational Center For Research Resources1999–2002
  • Phase I/II Trial Of Ironstecan In Patients With GliomaNational Center For Research Resources2001
  • Phase 2 Trial Of Thymidine/Carboplatin Therapy Of GliomaNational Center For Research Resources2001
  • Quantify Gene Expression: Prognosis &Therapy Response Stratification In GliomaNational Center For Research Resources1998

Hospital Affiliations

Dr. Timothy Cloughesy, Dr. Timothy Cloughesy, MD, Dr. T Cloughesy, Dr. Timothy Francis Cloughesy